Skip to main content

Table 3 Associations between endorsement of SCD-plus features and SCD-I domains with CSF-Aß-42 level

From: Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study

N = 205

CSF-Aß-42 level (pg/ml)

p a

 

M

(SD)

F

\( {\eta}_p^2 \)

SCD-plus features

 Decline in memory

Yes

n = 129

720

− 316

7.65**

.036

.006

No

n = 76

849

− 293

   

 Onset of SCD within the last 5 years

Yes

n = 120

722

− 312

6.07*

.029

.015

No

n = 85

833

− 306

   

 Particular concerns/worries

Yes

n = 113

727

− 309

3.68

.018

.056

No

n = 92

819

− 313

   

 The feeling of worse performance than others

Yes

n = 35

695

− 308

2.488

.012

.116

No

n = 170

783

− 313

   

 Confirmation by an informant

Yes

n = 81

695

− 315

4.19*

.032

.017

No

n = 124

816

− 304

   

SCD-I domains

 Decline in memory

Yes

n = 129

720

− 316

7.65**

.036

.006

No

n = 76

849

− 293

   

 Decline in language

Yes

n = 127

727

− 312

5.18*

.025

.024

No

n = 78

835

− 306

   

 Decline in attention

Yes

n = 62

738

− 349

.751

.004

.387

No

n = 143

781

− 297

   

 Decline in planning

Yes

n = 26

704

− 326

1.049

.005

.307

No

n = 179

777

− 312

   

 Decline in other

Yes

n = 48

716

− 302

1.65

.008

.201

No

n = 156

780

− 313

   
  1. M mean, SD standard deviation
  2. *p < .05
  3. **p < .01
  4. ***p < .001
  5. aAdjusted for age for the SCD-I domains and for age and education for the SCD-plus features, \( {\eta}_p^2 \) > .01 = small effect; \( {\eta}_p^2 \) > .06 = average effect; \( {\eta}_p^2 \) > .14 = large effect (according to Cohen 1988)